SCHEMBL527872

SCHEMBL527872

C=CCON(CC=C)CC=C

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17706899 0.85 MEN1 (0.39) MEN1POLBKMT2A
SCHEMBL7164576 0.79
SCHEMBL6703959 0.77
SCHEMBL4590882 0.74
SCHEMBL4375192 0.71 ALDH1A1 (0.31)
Alcohol SCHEMBL10361805 0.69 ALDH1A1 (0.32)
SCHEMBL4033325 0.69
SCHEMBL22612979 0.67
SCHEMBL8156421 0.67
SCHEMBL6688331 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4388022-A1 PROCESS FOR THE PREPARATION OF POLYCARBODIIMIDES WITH AZIRIDINE FUNCTIONS, WHICH MAY BE USED AS CROSSLINKING AGENT Stahl International B.V. (NL) 2024-06-26 EP claimed
WO-2023022591-A1 PROCESS FOR THE PREPARATION OF POLYCARBODIIMIDES WITH AZIRIDINE FUNCTIONS, WHICH MAY BE USED AS CROSSLINKING AGENT STAHL INTERNATIONAL B.V. (NL) 2023-02-23 WO claimed
US-9546301-B2 Process for the preparation of multifunctional polycarbodiimides which are used as crosslinking agents STAHL INTERNATIONAL B.V. (NL) 2017-01-17 US claimed
EP-2598555-B1 PROCESS FOR THE PREPARATION OF MULTIFUNCTIONAL POLYCARBODIIMIDES WHICH ARE USED AS CROSSLINKING AGENTS STAHL INT BV (NL) 2014-10-08 EP claimed
US-20130144006-A1 Process for the Preparation of Multifunctional Polycarbodiimides Which are Used as Crosslinking Agents STAHL INTERNATIONAL B.V. (NL) 2013-06-06 US claimed
EP-2598555-A1 PROCESS FOR THE PREPARATION OF MULTIFUNCTIONAL POLYCARBODIIMIDES WHICH ARE USED AS CROSSLINKING AGENTS STAHL INTERNATIONAL B.V. (NL) 2013-06-05 EP claimed
WO-2012015295-A1 PROCESS FOR THE PREPARATION OF MULTIFUNCTIONAL POLYCARBODIIMIDES WHICH ARE USED AS CROSSLINKING AGENTS STAHL INTERNATIONAL B.V. (NL) 2012-02-02 WO claimed
CN-101374876-B Process for the preparation of dispersions of cross-linking agents in water STAHL INTERNAT BV 2011-07-13 CN claimed
EP-1981922-B1 PROCESS FOR THE PREPARATION OF DISPERSIONS OF CROSS-LINKING AGENTS IN WATER STAHL INT BV (NL) 2009-07-15 EP claimed
CN-101374876-A Process for the preparation of dispersions of cross-linking agents in water STAHL INTERNAT BV (NL) 2009-02-25 CN claimed
EP-4388022-A1 PROCESS FOR THE PREPARATION OF POLYCARBODIIMIDES WITH AZIRIDINE FUNCTIONS, WHICH MAY BE USED AS CROSSLINKING AGENT Stahl International B.V. (NL) 2024-06-26 EP disclosed
JP-2023113573-A Polyimide precursor JFEケミカル株式会社 2023-08-16 JP disclosed
WO-2023022591-A1 PROCESS FOR THE PREPARATION OF POLYCARBODIIMIDES WITH AZIRIDINE FUNCTIONS, WHICH MAY BE USED AS CROSSLINKING AGENT STAHL INTERNATIONAL B.V. (NL) 2023-02-23 WO disclosed
US-20220054392-A1 MULTICOMPONENT IN SITU COLORATION COMPOSITION WELLA INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) 2022-02-24 US disclosed
EP-3890683-A1 MULTICOMPONENT IN SITU COLORATION COMPOSITION HFC Prestige International Holding Switzerland S.a.r.l. (CH) 2021-10-13 EP disclosed
US-5026700-A Certain quinolines and thienopyridines as excitatory amino acid antagonists MERRELL DOW PHARMACEUTICALS (US) 1991-06-25 US disclosed
EP-0398283-A1 Excitatory amino acid antagonists MERRELL DOW PHARMACEUTICALS INC. (US) 1990-11-22 EP disclosed
EP-0255677-A1 Process for producing Polyamino-hydroxy compounds containing urethane and/or urea groups and their use in the production of polyurea urethanes BAYER AG (DE) 1988-02-10 EP disclosed
EP-0219035-A2 Process for the preparation of polyamines, and their use in the preparation of polyurethanes BAYER AG (DE) 1987-04-22 EP disclosed
EP-0097298-A2 Polyamines, process for producing polyamines and their use in the production of polyurethanes BAYER AG (DE) 1984-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220054392-A1 MULTICOMPONENT IN SITU COLORATION COMPOSITION KRT18, PRKDC, VIM MEN1 1309/4885POLB 1565/4885KMT2A 1653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.